- Home
- BPMC vs NVMI Comparison
BPMC vs NVMI Comparison
Compare BPMC & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- NVMI
- Stock Information
- Founded
- BPMC 2008
- NVMI 1993
- Country
- BPMC United States
- NVMI Israel
- Employees
- BPMC N/A
- NVMI N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- NVMI Electronic Components
- Sector
- BPMC Health Care
- NVMI Technology
- Exchange
- BPMC Nasdaq
- NVMI Nasdaq
- Market Cap
- BPMC 5.9B
- NVMI 5.6B
- IPO Year
- BPMC 2015
- NVMI 2000
- Fundamental
- Price
- BPMC $90.14
- NVMI $193.53
- Analyst Decision
- BPMC Buy
- NVMI Buy
- Analyst Count
- BPMC 20
- NVMI 6
- Target Price
- BPMC $120.79
- NVMI $227.80
- AVG Volume (30 Days)
- BPMC 667.8K
- NVMI 181.6K
- Earning Date
- BPMC 02-13-2025
- NVMI 02-13-2025
- Dividend Yield
- BPMC N/A
- NVMI N/A
- EPS Growth
- BPMC N/A
- NVMI 26.92
- EPS
- BPMC N/A
- NVMI 5.34
- Revenue
- BPMC $434,415,000.00
- NVMI $611,849,000.00
- Revenue This Year
- BPMC $108.09
- NVMI $30.81
- Revenue Next Year
- BPMC $39.34
- NVMI $18.41
- P/E Ratio
- BPMC N/A
- NVMI $36.23
- Revenue Growth
- BPMC 100.93
- NVMI 14.38
- 52 Week Low
- BPMC $72.24
- NVMI $128.74
- 52 Week High
- BPMC $121.90
- NVMI $247.21
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- NVMI 53.30
- Support Level
- BPMC $86.02
- NVMI $187.94
- Resistance Level
- BPMC $98.41
- NVMI $207.64
- Average True Range (ATR)
- BPMC 3.28
- NVMI 7.64
- MACD
- BPMC -0.76
- NVMI 0.93
- Stochastic Oscillator
- BPMC 33.04
- NVMI 38.30
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About NVMI Nova Ltd.
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.